Retrospective Analysis of Pain After Nerve Block in Surgical Patients
Study Details
Study Description
Brief Summary
This is a retrospective study looking at patients who received a nerve block for surgery and assessing pain after the nerve block resolves, with or without an educational intervention, over two periods of time.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Regional anesthesia (RA) is a vital tool that can serve as the primary anesthetic or as part of a multimodal perioperative pain regimen. RA is strongly associated with decreased acute and persistent pain and opioid consumption postoperatively. However, some patients experience an acute worsening of pain into the severe range around the time of RA resolution, also known as "rebound pain" (RP). The incidence of RP has been reported as high as 40-50% after a single shot nerve block for patients undergoing ambulatory surgery.
This retrospective study aims to look at patients who received a nerve block for surgery and assessing pain after the nerve block resolves in the presence and absence of certain interventions, such as a multidisciplinary educational intervention.
The investigators will assess patients who received a primary total knee arthroplasty who received a single shot adductor canal nerve block, received pericapsular injection by the surgeon, and had a length of stay > 16 hours.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| TKA with nerve block no intervention Patients who received a single shot adductor canal nerve block prior to total knee arthroplasty surgery January 2017-December 2017 |
|
| TKA with nerve block with intervention Patients who received a single shot adductor canal nerve block prior to total knee arthroplasty surgery during March 2019-March 2020, and received an educational intervention |
Other: Educational intervention
Multidisciplinary educational intervention was performed by orthopedic, anesthesia, and nursing team. This included a discussion of the patient's pain plan and a patient visit.
|
Outcome Measures
Primary Outcome Measures
- Overall pain score [8-16 hours]
Difference in area under the curve of pain scores, numerical pain rating scale 0-10, 8-16 hours after nerve block between the two cohorts (educational intervention and non-educational intervention time periods)
Secondary Outcome Measures
- Difference in maximum pain score post-nerve block [8-16 hours]
Difference in maximum pain score, numerical pain rating scale 0-10, 8-16 hours after nerve block between the two cohorts
- Difference in incidence of rebound pain [8-16 hours]
Difference in incidence pain score ≥ 7 between 8-16 hours post nerve block between the two cohorts
Other Outcome Measures
- Comparison of evening opioids given [8-16 hours]
Comparison of if evening opioids were or were not given (yes/no) between the two cohorts
- Difference in total opioids given [8-16 hours]
Difference in total opioids given (mEq of morphine) between the two cohorts
- Difference in length of stay [0-30 days]
Difference in length of stay (days) between the two cohorts
Eligibility Criteria
Criteria
Inclusion Criteria:
-
primary total knee arthroplasty
-
received an adductor canal nerve block
-
received pericapsular injection by surgeon intraoperatively
-
admitted for overnight stay and > 16 hours post-nerve block
Exclusion Criteria:
-
age < 18
-
prior total knee arthroplasty on ipsilateral knee
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Brigham and Women's Hospital
Investigators
- Principal Investigator: Yun-Yun K Chen, MD, Brigham and Women's Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2023P000514